| Dr Aurelio Laing Iii, MD | |
|
119 E Academy St, Del Rio, TX 78840-6072 | |
| (830) 422-3305 | |
| (855) 458-3317 |
| Full Name | Dr Aurelio Laing Iii |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 119 E Academy St, Del Rio, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740312867 | NPI | - | NPPES |
| 207820601 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | N3127 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Val Verde Regional Medical Center | Del rio, TX | Hospital |
| Del Rio Nursing And Rehabilitation Center | Del rio, TX | Nursing home |
| La Vida Serena Nursing And Rehabilitation | Del rio, TX | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Texas Hospitalist Associates Llc | 6608024633 | 11 |
| United Medical Centers | 7618957135 | 17 |
News Archive
Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population. A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate.
SARcode Corporation announced today the results of its Phase 1 randomized, double-masked, placebo-controlled trial of the safety, tolerability, and pharmacokinetics of single- and multiple-escalating doses of SAR 1118 Ophthalmic Solution in healthy volunteers.
Discrimination felt by teenagers based on their social class background can contribute to physiologic changes associated with poorer health, according to a new study led by a University of Wisconsin-Madison researcher.
Ovarian cancer is the deadliest of all cancers affecting the female reproductive system with very few effective treatments available. Prognosis is even worse among patients with certain subtypes of the disease. Now, researchers at The Wistar Institute have identified a new therapeutic target in a particularly aggressive form of ovarian cancer, paving the way for what could be the first effective targeted therapy of its kind for the disease.
› Verified 6 days ago
| Entity Name | United Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710980669 PECOS PAC ID: 7618957135 Enrollment ID: O20040817000497 |
News Archive
Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population. A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate.
SARcode Corporation announced today the results of its Phase 1 randomized, double-masked, placebo-controlled trial of the safety, tolerability, and pharmacokinetics of single- and multiple-escalating doses of SAR 1118 Ophthalmic Solution in healthy volunteers.
Discrimination felt by teenagers based on their social class background can contribute to physiologic changes associated with poorer health, according to a new study led by a University of Wisconsin-Madison researcher.
Ovarian cancer is the deadliest of all cancers affecting the female reproductive system with very few effective treatments available. Prognosis is even worse among patients with certain subtypes of the disease. Now, researchers at The Wistar Institute have identified a new therapeutic target in a particularly aggressive form of ovarian cancer, paving the way for what could be the first effective targeted therapy of its kind for the disease.
› Verified 6 days ago
| Entity Name | Hni Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366735169 PECOS PAC ID: 6406028810 Enrollment ID: O20111031000750 |
News Archive
Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population. A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate.
SARcode Corporation announced today the results of its Phase 1 randomized, double-masked, placebo-controlled trial of the safety, tolerability, and pharmacokinetics of single- and multiple-escalating doses of SAR 1118 Ophthalmic Solution in healthy volunteers.
Discrimination felt by teenagers based on their social class background can contribute to physiologic changes associated with poorer health, according to a new study led by a University of Wisconsin-Madison researcher.
Ovarian cancer is the deadliest of all cancers affecting the female reproductive system with very few effective treatments available. Prognosis is even worse among patients with certain subtypes of the disease. Now, researchers at The Wistar Institute have identified a new therapeutic target in a particularly aggressive form of ovarian cancer, paving the way for what could be the first effective targeted therapy of its kind for the disease.
› Verified 6 days ago
| Entity Name | South Texas Hospitalist Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790045664 PECOS PAC ID: 6608024633 Enrollment ID: O20120918000181 |
News Archive
Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population. A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate.
SARcode Corporation announced today the results of its Phase 1 randomized, double-masked, placebo-controlled trial of the safety, tolerability, and pharmacokinetics of single- and multiple-escalating doses of SAR 1118 Ophthalmic Solution in healthy volunteers.
Discrimination felt by teenagers based on their social class background can contribute to physiologic changes associated with poorer health, according to a new study led by a University of Wisconsin-Madison researcher.
Ovarian cancer is the deadliest of all cancers affecting the female reproductive system with very few effective treatments available. Prognosis is even worse among patients with certain subtypes of the disease. Now, researchers at The Wistar Institute have identified a new therapeutic target in a particularly aggressive form of ovarian cancer, paving the way for what could be the first effective targeted therapy of its kind for the disease.
› Verified 6 days ago
| Entity Name | Hni Hospital Services Of Texas Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053884080 PECOS PAC ID: 5890028021 Enrollment ID: O20190603002968 |
News Archive
Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population. A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate.
SARcode Corporation announced today the results of its Phase 1 randomized, double-masked, placebo-controlled trial of the safety, tolerability, and pharmacokinetics of single- and multiple-escalating doses of SAR 1118 Ophthalmic Solution in healthy volunteers.
Discrimination felt by teenagers based on their social class background can contribute to physiologic changes associated with poorer health, according to a new study led by a University of Wisconsin-Madison researcher.
Ovarian cancer is the deadliest of all cancers affecting the female reproductive system with very few effective treatments available. Prognosis is even worse among patients with certain subtypes of the disease. Now, researchers at The Wistar Institute have identified a new therapeutic target in a particularly aggressive form of ovarian cancer, paving the way for what could be the first effective targeted therapy of its kind for the disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aurelio Laing Iii, MD Po Box 1470, Eagle Pass, TX 78853-1470 Ph: (830) 773-8917 | Dr Aurelio Laing Iii, MD 119 E Academy St, Del Rio, TX 78840-6072 Ph: (830) 422-3305 |
News Archive
Psoriasis is a chronic inflammatory skin disorder that affects approximately 2% of the world's population. A group of inflammatory molecules known as interleukins activate an immune response that causes itchy skin, but it is unclear how the skin cells and immune cells communicate.
SARcode Corporation announced today the results of its Phase 1 randomized, double-masked, placebo-controlled trial of the safety, tolerability, and pharmacokinetics of single- and multiple-escalating doses of SAR 1118 Ophthalmic Solution in healthy volunteers.
Discrimination felt by teenagers based on their social class background can contribute to physiologic changes associated with poorer health, according to a new study led by a University of Wisconsin-Madison researcher.
Ovarian cancer is the deadliest of all cancers affecting the female reproductive system with very few effective treatments available. Prognosis is even worse among patients with certain subtypes of the disease. Now, researchers at The Wistar Institute have identified a new therapeutic target in a particularly aggressive form of ovarian cancer, paving the way for what could be the first effective targeted therapy of its kind for the disease.
› Verified 6 days ago
Veronica Cadena, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2201 N Bedell Ave Ste A, Del Rio, TX 78840 Phone: 830-775-8700 | |
Dr. Mohan Ravindra Gadam, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 N Bedell Ave, Del Rio, TX 78840 Phone: 512-730-3056 Fax: 888-730-1925 | |
Vivian Viera, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1801 N Bedell Ave, Del Rio, TX 78840 Phone: 830-768-9200 | |
Gene V Haverlah, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 913 S Main St, Del Rio, TX 78840 Phone: 830-774-5534 Fax: 830-775-7525 | |
Antonio Cadena, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2201 N Bedell Ave Ste A, Del Rio, TX 78840 Phone: 830-775-8700 Fax: 830-775-8711 |